Trastuzumab in the treatment of non–small cell lung cancer-Reference-Cited by-同舟云学术

Trastuzumab in the treatment of non–small cell lung cancer

Published:2002-02 Issue:1 Volume:29 Page:59-65
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Azzoli Christopher G,Krug Lee M,Miller Vincent A,Kris Mark G,Mass Robert

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference46 articles.

1. Cancer Statistics, 2000;Greenlee;CA Cancer J Clin,2000

2. A randomized phase III trial of four chemotherapy regimens in advanced non–small cell lung cancer;Schiller;Proc Am Soc Clin Oncol,2000

3. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization;Pauletti;Oncogene,1996

4. Assessment of methods of tissue-based detection of the HER-2/neu alteration in human breast cancer: A direct comparison of fluorescence in situ hybridization and immunohistochemistry;Pauletti;J Clin Oncol,2000

5. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brigatinib combined with cetuximab in the fifth-line treatment of non-small cell lung cancer with EGFR p.C797S mutation in critically ill patients: a report of two cases and literature review;Anti-Cancer Drugs;2024-03-15

2. Targeting the EGF receptor family in non-small cell lung cancer—increased complexity and future perspectives;Cancer Biology & Medicine;2022-12-05

3. Ratiometric Fluorescence Monitoring of Antibody-Guided Drug Delivery to Cancer Cells;Bioconjugate Chemistry;2021-06-11

4. Genotype Driven Therapy for Non-Small Cell Lung Cancer: Resistance, Pan Inhibitors and Immunotherapy;Current Medicinal Chemistry;2020-09-25

5. Lung Carcinoma;Genomic Medicine;2019-09-27